Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis ; volume:14 ; number:1 ; day:17 ; month:10 ; year:2019 ; pages:1-9 ; date:12.2019
Radiation oncology ; 14, Heft 1 (17.10.2019), 1-9, 12.2019
- Creator
-
Luo, He-San
Huang, He-Cheng
Lin, Lian-Xing
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-019-1386-x
- URN
-
urn:nbn:de:101:1-2020021322040688980050
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Luo, He-San
- Huang, He-Cheng
- Lin, Lian-Xing
- SpringerLink (Online service)
Other Objects (12)
High-dose Methotrexate
Standard-dose versus high-dose radiotherapy with concurrent chemotherapy in esophageal cancer: A prospective randomized study
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
Cooperative binding mitigates the high-dose hook effect
High-dose methotrexate : pharmacokinetics in children and young adults
High-dose methotrexate in ICU patients: a retrospective study
Single high-dose buprenorphine for opioid craving during withdrawal
High-dose intravenous glucocorticoid induces hyperamylasemia: a case series
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
High-Dose Brolucizumab for Refractory Neovascular Age-Related Macular Degeneration Resistant to Standard-Dose Brolucizumab
High-dose versus low-dose iron sucrose in individuals undergoing maintenance haemodialysis: a retrospective study
High-dose Methotrexate
Standard-dose versus high-dose radiotherapy with concurrent chemotherapy in esophageal cancer: A prospective randomized study
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
Cooperative binding mitigates the high-dose hook effect
High-dose methotrexate : pharmacokinetics in children and young adults
High-dose methotrexate in ICU patients: a retrospective study
Single high-dose buprenorphine for opioid craving during withdrawal
High-dose intravenous glucocorticoid induces hyperamylasemia: a case series
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
High-Dose Brolucizumab for Refractory Neovascular Age-Related Macular Degeneration Resistant to Standard-Dose Brolucizumab
High-dose versus low-dose iron sucrose in individuals undergoing maintenance haemodialysis: a retrospective study
High-dose Methotrexate
Standard-dose versus high-dose radiotherapy with concurrent chemotherapy in esophageal cancer: A prospective randomized study
Concurrent chemo-radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer
Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer
Cooperative binding mitigates the high-dose hook effect
High-dose methotrexate : pharmacokinetics in children and young adults
High-dose methotrexate in ICU patients: a retrospective study
Single high-dose buprenorphine for opioid craving during withdrawal
High-dose intravenous glucocorticoid induces hyperamylasemia: a case series
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
High-Dose Brolucizumab for Refractory Neovascular Age-Related Macular Degeneration Resistant to Standard-Dose Brolucizumab